AccessibilityHelp
Eurofins Scientific Se logo

Eurofins Scientific Se(OTC) ERFSF

Market Cap$16.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)+516%
5 Year-14%
1 Year+36%
1 Month+9%
$95.27
-0.85%
-0.81Today
Eurofins Scientific Se last closing stock price
MetricPriceDate
Last closeUSD 96.082026-10-23
Eurofins Scientific Se stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+7.87%USD 89.072026-10-16
1 month+9.03%USD 88.122026-09-23
3 month+30.29%USD 73.752026-07-24
Year to date+32.66%USD 72.432025-12-31
1 year+36.43%USD 70.432025-10-23
3 year+102.92%USD 47.352023-10-24
5 year-14.25%USD 112.052021-10-22
Since inception+516.39%USD 15.592004-03-25

Eurofins Scientific Se Financials at a Glance

Market Cap

$16.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€14.52B

Net Income (TTM)

€962.16M

EPS (TTM)

$3.36

P/E Ratio

27.42

Dividend

$0.84

Beta (Volatility)

0.53 (Low)

Price

$95.27

Volume

188

Open

$97.88

Previous Close

$96.08

Daily Range

$95.27 - $97.88

52-Week Range

$64.95 - $97.88

Estimated Earnings Date

Mar 2, 2027

ERFSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eurofins Scientific Se

Eurofins Scientific SE is a global leader in analytical testing and laboratory solutions, offering a wide range of services across various sectors. Established in 1987, the company operates approximately 900 laboratories in 54 countries, utilizing around 200,000 analytical techniques to ensure product safety and compliance.

Products and Services
  • Comprehensive testing for food, pharmaceuticals, and environmental samples
  • Regulatory compliance and advisory services across multiple industries
  • Specialized solutions in biopharma, clinical diagnostics, and forensic science
Growth Outlook
  • Revenue of €3.70 billion reported in Q2 2026, showing consistent growth
  • Net income of €301.55 million in Q2 2026, reflecting strong profitability
  • Operating income margin of 13.48% indicates efficient cost management
Financial Highlights
  • Trailing twelve months (TTM) revenue of €14.56 billion, demonstrating robust demand
  • Net profit margin of 7.18% highlights effective operational efficiency
  • Dividend yield of 0.85% offers a steady return to shareholders
Eurofins Scientific SE stands out in the medical diagnostics and research industry, providing essential services that cater to safety and compliance needs across various sectors. The company's extensive portfolio includes food and feed testing, environmental assessments, and biopharma solutions, positioning it as a critical player in ensuring product integrity. Recent financial performance indicates a strong upward trajectory, with significant revenue growth and profitability metrics that reflect effective management and operational efficiency. The company's commitment to innovation and quality continues to drive its expansion in the global market, making it an attractive option for potential investors interested in the healthcare sector.
AI Generated • Oct 24, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

65,694

CEO

Gilles G. Martin, PhD

Website

www.eurofins.com

Headquarters

Luxembourg City, LU 1526, LU

ERFSF Financials

Key Financial Metrics (TTM)

Gross Margin

11.97%

Operating Margin

11.97%

Net Income Margin

7.18%

Return on Equity

14.81%

Return on Capital

10.26%

Return on Assets

4.77%

Earnings Yield

3.65%

Dividend Yield

0.88%

Payout Ratio

24.57%

Stock Overview

Market Cap

$16.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

173.60M

Volume

188

Avg. Volume

2.08K

Financials (TTM)

Gross Profit

€5.65B

Operating Income

€2.03B

EBITDA

€3.16B

Operating Cash Flow

€2.68B

Capital Expenditure

-€1.26B

Free Cash Flow

€1.42B

Cash & ST Invst.

€617.07M

Total Debt

€5.46B

Eurofins Scientific Se Performance Analysis

Eurofins Scientific Se annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 7,054,244,711-11.2%
20232023-12-31EUR 7,043,035,707-0.2%
20242024-12-31EUR 7,518,832,4476.8%
20252025-12-31EUR 8,234,217,5859.5%
Eurofins Scientific Se sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-313.3%
Q22025-06-302.3%
Q42025-12-312.0%
Q22026-06-300.3%
Eurofins Scientific Se annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 3.22-30.1%
20232023-12-31EUR 1.69-47.4%
20242024-12-31EUR 2.2633.4%
20252025-12-31EUR 2.8727.1%
Eurofins Scientific Se sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-319.0%
Q22025-06-306.4%
Q42025-12-316.0%
Q22026-06-3032.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€3.70B

+8.1%

Gross Profit

€498.25M

-34.1%

Gross Margin

13.48%

N/A

Market Cap

$16.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$253.90K

N/A

Employees

65,694

N/A

Net Income

€301.55M

+36.6%

EBITDA

€795.81M

+3.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€617.07M

-9.4%

Total Debt

€5.46B

+54.2%

Accounts Receivable

€1.55B

+9.5%

Inventory

€144.78M

+1.7%

Long Term Debt

€4.69B

+39.1%

Short Term Debt

€770.84M

+351.6%

Return on Assets

4.77%

N/A

Return on Invested Capital

10.26%

N/A

Free Cash Flow

€383.43M

+22.6%

Operating Cash Flow

€574.14M

+8.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RVTYRevvity, Inc.
$160.05+0.80%
MEDPMedpace Holdings, Inc.
$674.37+0.77%
IDXXIDEXX Laboratories, Inc.
$568.17+1.39%
DHRDanaher Corporation
$232.27+0.77%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$12.28-19.00%
EWZiShares - iShares Msci Brazil ETF
$33.17-22.13%
ITUBItaú Unibanco
$7.53-22.18%
XPXP
$15.59-48.75%

Questions About ERFSF

What is the current price of Eurofins Scientific Se?

Eurofins Scientific Se is trading at $95.27 per share.

What is the 52-week range for Eurofins Scientific Se?

Over the past 52 weeks, Eurofins Scientific Se has traded between $64.95 and $97.88.

How much debt does Eurofins Scientific Se have?

As of the most recent reporting period, Eurofins Scientific Se reported total debt of €6.38B.

How much cash does Eurofins Scientific Se have on hand?

Eurofins Scientific Se reported €929.22M in cash and cash equivalents in its most recent financial results.

What is Eurofins Scientific Se’s dividend yield?

Eurofins Scientific Se currently has a dividend yield of 0.88%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services